Literature DB >> 14726145

Gamma scintigraphic evaluation of film-coated tablets intended for colonic or biphasic release.

Kwabena Ofori-Kwakye1, John T Fell, Harbans L Sharma, Anne-Marie Smith.   

Abstract

The gastrointestinal transit and in vivo drug release behaviour of a film-coated tablet formulation was investigated in five healthy human subjects using the technique of gamma scintigraphy. The film coating system consisted of a mixture of pectin, chitosan and HPMC in a ratio of 6:1:0.37 applied to 750 mg cores at a coat weight gain of 9%. The estimated mean values of the gastric emptying time (62+/-17 min), small intestinal transit time (219+/-53 min), ileocaecal junction lag time (79+/-30 min) and the colon arrival time (345+/-33 min), were similar to published values for the transit of similar sized tablets in humans. The amount of radioactive tracer released from the labelled tablets was minimal when the tablets were in the stomach and the small intestine. There was increased release of radioactivity when the tablets were in the colon due to increased degradation of the film coatings by pectinolytic enzymes resident in the colon. The pectin/chitosan/HPMC film coating system thus acts as a colonic delivery system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726145     DOI: 10.1016/j.ijpharm.2003.11.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Meal-induced acceleration of tablet transit through the human small intestine.

Authors:  Hala M Fadda; Emma L McConnell; Michael D Short; Abdul W Basit
Journal:  Pharm Res       Date:  2008-11-04       Impact factor: 4.200

2.  Characterization of soy polysaccharide and its in vitro and in vivo evaluation for application in colon drug delivery.

Authors:  B M Ursekar; P S Soni; Abhijit A Date; M S Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2012-06-28       Impact factor: 3.246

Review 3.  Pectin matrix as oral drug delivery vehicle for colon cancer treatment.

Authors:  Tin Wui Wong; Gaia Colombo; Fabio Sonvico
Journal:  AAPS PharmSciTech       Date:  2010-12-31       Impact factor: 3.246

Review 4.  Advances in colonic drug delivery.

Authors:  Abdul W Basit
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Ambroxol Lozenge Bioavailability : Part II - Analysis of Additional Systemic AvailabilityPart I of this article was published in Clin Drug Invest 2003; 23 (4): 273-80.

Authors:  Damrongsak Faroongsarng; Malee Rojpibulstit; Srirat Kasiwong; Narubodee Phadoongsombat
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

6.  Preparation and gamma scintigraphic evaluation of colon specific pellets of ketoprofen prepared by powder layering technology.

Authors:  M Subhabrota; R Souvik; C Subhadeep
Journal:  Daru       Date:  2011       Impact factor: 3.117

7.  In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency.

Authors:  Ofosua Adi-Dako; Kwabena Ofori-Kwakye; Mariam El Boakye-Gyasi; Samuel Oppong Bekoe; Samuel Okyem
Journal:  J Drug Deliv       Date:  2017-12-24

8.  Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.

Authors:  Stefan Willmann; Corina Becker; Rolf Burghaus; Katrin Coboeken; Andrea Edginton; Jörg Lippert; Hans-Ulrich Siegmund; Kirstin Thelen; Wolfgang Mück
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

9.  Physicochemical and Antimicrobial Properties of Cocoa Pod Husk Pectin Intended as a Versatile Pharmaceutical Excipient and Nutraceutical.

Authors:  Ofosua Adi-Dako; Kwabena Ofori-Kwakye; Samuel Frimpong Manso; Mariam El Boakye-Gyasi; Clement Sasu; Mike Pobee
Journal:  J Pharm (Cairo)       Date:  2016-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.